The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Terheyden, P.
Right arrow Articles by Becker, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Terheyden, P.
Right arrow Articles by Becker, J. C.
The Journal of Immunology, 2000, 164: 6633-6639.
Copyright © 2000 by The American Association of Immunologists

CD40-Ligated Dendritic Cells Effectively Expand Melanoma-Specific CD8+ CTLs and CD4+ IFN-{gamma}-Producing T Cells from Tumor-Infiltrating Lymphocytes1

Patrick Terheyden*, Per thor Straten{dagger}, Eva-B. Bröcker*, Eckhart Kämpgen* and Jürgen C. Becker2,*

* Department of Dermatology, School of Medicine, University of Würzburg, Würzburg, Germany; and {dagger} Department of Tumor Cell Biology, Danish Cancer Society, Copenhagen, Denmark

Professional APC, notably dendritic cells (DC), are necessary for stimulation and expansion of naive T cells. By means of murine models, the interaction between CD40 on DC and its ligand CD154 has been recognized as an important element for conditioning of DC to prime and expand CTL. We translated these findings into the human system, scrutinizing the ability of DC to initiate clonal expansion of single T cells. DC generated under completely autologous conditions from peripheral blood monocytes were cocultured at a rate of 0.3 cell/well with melanoma-infiltrating T cells; this procedure guaranteed that either a CD4+ or a CD8+ cell interacted with the DC, thus avoiding the contact of more than one T cell to the DC. In the absence of further stimulation, this cloning protocol yielded almost exclusively CD4+ T cell clones that predominantly exhibited a Th2 phenotype. However, cross-linking of CD40 on DC resulted in the induction of IFN-{gamma}-producing Th1 CD4+ T cell clones. In addition, CD40-activated DC were capable of expanding CD8+ CTL clones. The ratio of CD4 to CD8 T cell clones corresponded to the ratio present in the initial tumor-infiltrating lymphocyte preparation. The CTL clones efficiently lysed autologous tumor cells whereas autologous fibroblasts or MHC-mismatched melanoma cells were not killed. Our findings support the critical role of CD40/CD154 interactions for the induction of cellular immune responses.




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. G. Joyee, H. Qiu, Y. Fan, S. Wang, and X. Yang
Natural Killer T Cells Are Critical for Dendritic Cells to Induce Immunity in Chlamydial Pneumonia
Am. J. Respir. Crit. Care Med., October 1, 2008; 178(7): 745 - 756.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S. Yang, K.-Y. Tsang, and J. Schlom
Induction of Higher-Avidity Human CTLs by Vector-Mediated Enhanced Costimulation of Antigen-Presenting Cells
Clin. Cancer Res., August 1, 2005; 11(15): 5603 - 5615.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Stumbles, R. Himbeck, J. A. Frelinger, E. J. Collins, R. A. Lake, and B. W. S. Robinson
Cutting Edge: Tumor-Specific CTL Are Constitutively Cross-Armed in Draining Lymph Nodes and Transiently Disseminate to Mediate Tumor Regression following Systemic CD40 Activation
J. Immunol., November 15, 2004; 173(10): 5923 - 5928.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Younes and M. E. Kadin
Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer Therapy
J. Clin. Oncol., September 15, 2003; 21(18): 3526 - 3534.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Ng-Cashin, J. J. Kuhns, S. E. Burkett, J. D. Powderly, R. R. Craven, H. W. van Deventer, S. L. Kirby, and J. S. Serody
Host Absence of CCR5 Potentiates Dendritic Cell Vaccination
J. Immunol., April 15, 2003; 170(8): 4201 - 4208.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. D. de Gruijl, S. A. Luykx-de Bakker, B. W. Tillman, A. J. M. van den Eertwegh, J. Buter, S. M. Lougheed, G. J. van der Bij, A. M. Safer, H. J. Haisma, D. T. Curiel, et al.
Prolonged Maturation and Enhanced Transduction of Dendritic Cells Migrated from Human Skin Explants After In Situ Delivery of CD40-Targeted Adenoviral Vectors
J. Immunol., November 1, 2002; 169(9): 5322 - 5331.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
C. Termeer, H. Johannsen, T. Braun, A. Renkl, T. Ahrens, R. W. Denfeld, M. B. Lappin, J. M. Weiss, and J. C. Simon
The role of CD44 during CD40 ligand-induced dendritic cell clustering and maturation
J. Leukoc. Biol., November 1, 2001; 70(5): 715 - 722.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2000 by The American Association of Immunologists, Inc. All rights reserved.